Early Oxidative Stress Response in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Transatlantic Study
Table 1
Baseline clinical characteristics.
TAVR ()
SAVR ()
value
Age,
0.02
Female, (%)
25 (65.8)
9 (40.9)
0.06
Caucasian, (%)
17 (44.7)
8 (36.4)
0.47
BMI,
0.67
Hypertension, (%)
30 (78.9)
17 (77.3)
0.88
Type-2 diabetes, (%)
15 (39.5)
3 (13.6)
0.03
Previous smoking, (%)
17 (44.7)
3 (13.6)
0.01
Hypercholesterolemia, (%)
16 (42.1)
8 (36.4)
0.66
Previous myocardial infarction, (%)
11 (28.9)
0
0.01
Coronary artery disease
17 (44.7)
4 (9.1)
0.04
1-vessel CAD
4
4
2-vessel CAD
7
0
3-vessel CAD
6
0
Previous PCI, (%)
6 (15.8)
2 (9.1)
0.46
Previous CABG, (%)
11 (28.9)
0
0.01
Previous CVA/TIA, (%)
3 (7.9)
3 (13.6)
0.47
Peripheral vascular disease, (%)
5 (13.2)
4 (18.2)
0.61
Chronic lung disease, (%)
9 (23.7)
2 (9.1)
0.16
Chronic renal insufficiency
22 (57.9)
7 (31.8)
0.05
History of atrial fibrillation, (%)
14 (36.8)
3 (13.6)
0.05
eGFR (mL/min)
0.10
Hemoglobin (g/dL)
0.26
STS risk score, ±SD
<0.01
Logistic Euroscore 2, ±SD
<0.01
BMI = body mass index; CAD = coronary artery disease; CABG = coronary artery bypass grafting; CVA = cerebrovascular accident; CHF = congestive heart failure; eGFR = estimated glomerular filtration rate; PCI = percutaneous coronary intervention; SD = standard deviation; STS = Society of Thoracic Surgeons; TAVR = transcatheter aortic valve replacement; TIA = transient ischemic attack.
